| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Tyler Zeronda | CFO | 2026-07-23 | 22,516 | $0.90 | $20.22kSell |
| David Domzalski | CEO;Pres | 2026-07-23 | 79,391 | $0.90 | $71.29kSell |
| Mutya Harsch | CLO | 2026-07-23 | 22,516 | $0.90 | $20.22kSell |
| Iain Stuart | CSci | 2026-07-23 | 15,405 | $0.90 | $13.83kSell |
| Mutya Harsch | CHIEF LEGAL OFFICER AND GC | 2026-06-30 | 3,464 | $0.65 | $2.26kSell |
| David Domzalski | PRESIDENT AND CEO | 2026-06-30 | 12,214 | $0.65 | $7.95kSell |
| Iain Stuart | CHIEF SCIENTIFIC OFFICER | 2026-06-30 | 2,370 | $0.65 | $1.54kSell |
| Tyler Zeronda | CHIEF FINANCIAL OFFICER | 2026-06-30 | 3,464 | $0.65 | $2.26kSell |
| David Domzalski | PRESIDENT AND CEO | 2026-05-29 | 30,791 | $0.31 | $9.55kBuy |
| Mutya Harsch | CHIEF LEGAL OFFICER AND GC | 2026-03-31 | 4,007 | $0.60 | $2.40kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Perceptive Advisors LLC | 194.83% | 5,201,366 | $140.49M | Insider |
| Albert Cha | 150.25% | 4,011,236 | $108.34M | Insider |
| Vivo Capital VIII LLC | 150.25% | 4,011,236 | $108.34M | Insider |
| Remeditex Ventures LLC | 103.44% | 2,761,663 | $74.59M | Insider |
| Presidio Partners 2007 GP LP | 97.71% | 2,608,540 | $70.46M | Insider |
| Venbio Global Strategic Fund II LP | 54.74% | 1,461,552 | $39.48M | Insider |
| Merck Co Inc | 46.57% | 1,243,168 | $33.58M | Insider |
| Fmr LLC | 41.88% | 1,118,054 | $30.20M | Insider |
| Ai Biotechnology LLC | 41.82% | 1,116,585 | $30.16M | Insider |
| Steven L. Basta | 31.99% | 853,942 | $23.06M | Insider |